Citations

Showing 10 of 108094 citations.

Faculty Opinions recommendation of Ribothrypsis, a novel process of canonical mRNA decay, mediates ribosome-phased mRNA endonucleolysis.
Hu, Wenqian

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | March 28, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.732803865.793544079 Get It

Newborn screening for Pompe disease: impact on families
Pruniski, Brianna, Lisi, Emily C., Ali, Nadia

Mayo Clinic

Journal of Inherited Metabolic Disease | March 28, 2018 | Volume: 41 | Issue: 6 | Pages: 1189-1203

10.1007/s10545-018-0159-2 | PMID 29594646 Get It

AbstractPompe disease (PD) is an autosomal recessive lysosomal storage disorder causing progressive glycogen accumulation in muscles, with variability in age of onset and severity. For infantile‐onset PD (IOPD), initiation of early treatment can be life‐saving; however, current newborn screening (NBS) technology cannot distinguish IOPD from late‐onset PD (LOPD) without clinical workup. Therefore, families of LOPD infants diagnosed by NBS may now spend years or even decades aware of their illness before symptoms appear, creating a pre‐symptomatic awareness phase with which the medical community has little experience. The present study examines the effects of receiving a positive NBS result for PD on families. In‐depth qualitative interviews were conducted with mothers of nine children (three IOPD and six LOPD) diagnosed via NBS, exploring their experiences, understanding of PD, how they are coping, and what impact diagnosis is having on family life. Interviews were coded using MaxQDA v.12 and analyzed for thematic trends. While overall opinion of NBS was favorable, it is clear many of the concerns anticipated by HCPs, patients, and families regarding NBS for late‐onset LSDs are being realized to varying degrees; LOPD families are becoming patients‐in‐waiting. Increased fear/anxiety and living with uncertainty (regarding diagnosis, their children's future, and when to start treatment) were predominant themes, with all families voicing considerable emotional reactions and varied social and healthcare support concerns. Coping strategies and psychosocial challenges are interpreted using Rolland & Williams’ Family Systems Genetic Illness model. Recommendations for improvement in delivery of service, as well as families’ advice for future parents and HCPs, are discussed.
Comparing Pulmonary Arterial Wedge Pressure and Left Ventricular End Diastolic Pressure for Assessment of Left-Sided Filling Pressures
Reddy, Yogesh N.V. , El‐Sabbagh, Abdallah, Nishimura, Rick , Nishimura, Rick A.

Mayo Clinic

JAMA Cardiology | March 28, 2018 | Volume: 3 | Issue: 6 | Pages: 453

10.1001/jamacardio.2018.0318 | PMID 29590308 Get It

New-onset insulin-dependent diabetes due to nivolumab
Zaied, Ali, Aktürk, Halis Kaan , Lee, Augustine S. , Zaied, Ali A, Joseph, Richard W.

Mayo Clinic

Endocrinology, Diabetes & Metabolism Case Reports | March 28, 2018 | Volume: 2018 | Issue: No issue available | Pages: No page available

10.1530/edm-17-0174 | PMID 29623210 Get It

Summary Nivolumab, a monoclonal antibody against programmed cell death-1 receptor, is increasingly used in advanced cancers. While nivolumab use enhances cancer therapy, it is associated with increased immune-related adverse events. We describe an elderly man who presented in ketoacidosis after receiving nivolumab for metastatic renal cell carcinoma. On presentation, he was hyperpneic and laboratory analyses showed hyperglycemia and anion-gapped metabolic acidosis consistent with diabetic ketoacidosis. No other precipitating factors, besides nivolumab, were identified. Pre-nivolumab blood glucose levels were normal. The patient responded to treatment with intravenous fluids, insulin and electrolyte replacement. He was diagnosed with insulin-dependent autoimmune diabetes mellitus secondary to nivolumab. Although nivolumab was stopped, he continued to require multiple insulin injection therapy till his last follow-up 7 months after presentation. Clinicians need to be alerted to the development of diabetes mellitus and diabetic ketoacidosis in patients receiving nivolumab. Learning points: Diabetic ketoacidosis should be considered in the differential of patients presenting with metabolic acidosis following treatment with antibodies to programmed cell death-1 receptor (anti-PD-1). Autoimmune islet cell damage is the presumed mechanism for how insulin requiring diabetes mellitus can develop de novo following administration of anti-PD-1. Because anti-PD-1 works by the activation of T-cells and reduction of ‘self-tolerance’, other autoimmune disorders are likely to be increasingly recognized with increased use of these agents.
Insulin increases ventilation during euglycemia in humans
Barbosa, Thales C. , Kaur, Jasdeep , Holwerda, Seth W. , Young, Colin N. , Curry, Timothy B. , Thyfault, John P. , Limberg, Jacqueline K. , Joyner, Michael J. , Fadel, Paul J.

Mayo Clinic

American Journal of Physiology-Regulatory, Integrative and Comparative Physiology | March 28, 2018 | Volume: 315 | Issue: 1 | Pages: R84-R89

10.1152/ajpregu.00039.2018 | PMID 29590558 Get It

Evidence from animal studies indicates that hyperinsulinemia, without changes in glucose, increases ventilation via a carotid body-mediated mechanism. However, whether insulin elevates ventilation in humans independently of changes in glucose remains unclear. Therefore, we tested the hypothesis that insulin increases ventilation in humans during a hyperinsulinemic-euglycemic clamp in which insulin was elevated to postprandial concentrations while glucose was maintained at fasting concentrations. First, in 16 healthy young men ( protocol 1), we retrospectively analyzed respiration rate and estimated tidal volume from a pneumobelt to calculate minute ventilation during a hyperinsulinemic-euglycemic clamp. In addition, for a direct assessment of minute ventilation during a hyperinsulinemic-euglycemic clamp, we retrospectively analyzed breath-by-breath respiration rate and tidal volume from inspired/expired gasses in an additional 23 healthy young subjects ( protocol 2). Clamp infusion elevated minute ventilation from baseline in both protocols ( protocol 1: +11.9 ± 4.6% baseline, P = 0.001; protocol 2: +9.5 ± 3.8% baseline, P = 0.020). In protocol 1, peak changes in both respiration rate (+13.9 ± 3.0% baseline, P < 0.001) and estimated tidal volume (+16.9 ± 4.1% baseline, P = 0.001) were higher than baseline during the clamp. In protocol 2, tidal volume primarily increased during the clamp (+9.7 ± 3.7% baseline, P = 0.016), as respiration rate did not change significantly (+0.2 ± 1.8% baseline, P = 0.889). Collectively, we demonstrate for the first time in humans that elevated plasma insulin increases minute ventilation independent of changes in glucose.
Synthetic Lethality of PARP Inhibition and Ionizing Radiation is p53-dependent
Sizemore, Steven T. , Mohammad, Rahman, Nowsheen, Somaira , Ostrowski, Michael C. , Chakravarti, Arnab , Xia, Fen , Chakravarti, Arnab , Nowsheen, Somaira , Sizemore, Gina M. , Yu, Hao , Chakravarti, Arnab

Mayo Clinic

Molecular Cancer Research | March 28, 2018 | Volume: 16 | Issue: 7 | Pages: 1092-1102

10.1158/1541-7786.mcr-18-0106 | PMID 29592899 Get It

Abstract PARP inhibitors (PARPi) are potentially effective therapeutic agents capable of inducing synthetic lethality in tumors with deficiencies in homologous recombination (HR)-mediated DNA repair such as those carrying BRCA1 mutations. However, BRCA mutations are rare, the majority of tumors are proficient in HR repair, and thus most tumors are resistant to PARPi. Previously, we observed that ionizing radiation (IR) initiates cytoplasmic translocation of BRCA1 leading to suppression of HR-mediated DNA repair and induction of synthetic PARPi lethality in wild-type BRCA1 and HR-proficient tumor cells. The tumor suppressor p53 was identified as a key factor that regulates DNA damage–induced BRCA1 cytoplasmic sequestration following IR. However, the role of p53 in IR-induced PARPi sensitization remains unclear. This study elucidates the role of p53 in IR-induced PARPi cytotoxicity in HR-proficient cancer cells and suggests p53 status may help define a patient population that might benefit from this treatment strategy. Sensitization to PARPi following IR was determined in vitro and in vivo utilizing human breast and glioma tumor cells carrying wild-type BRCA1 and p53, and in associated cells in which p53 function was modified by knockdown or mutation. In breast and glioma cells with proficient HR repair, IR-induced BRCA1 cytoplasmic sequestration, HR repair inhibition, and subsequent PARPi sensitization in vitro and in vivo was dependent upon functional p53. Implications: Implications: p53 status determines PARP inhibitor sensitization by ionizing radiation in multiple BRCA1 and HR-proficient tumor types and may predict which patients are most likely to benefit from combination therapy. Mol Cancer Res; 16(7); 1092–102. ©2018 AACR.
The role of suboptimal mitochondrial function in vulnerability to post‐traumatic stress disorder
Preston, Graeme , Kirdar, Faisal, Kozicz, Tamás

Mayo Clinic

Journal of Inherited Metabolic Disease | March 28, 2018 | Volume: 41 | Issue: 4 | Pages: 585-596

10.1007/s10545-018-0168-1 | PMID 29594645 Get It

AbstractPost‐traumatic stress disorder remains the most significant psychiatric condition associated with exposure to a traumatic event, though rates of traumatic event exposure far outstrip incidence of PTSD. Mitochondrial dysfunction and suboptimal mitochondrial function have been increasingly implicated in several psychopathologies, and recent genetic studies have similarly suggested a pathogenic role of mitochondria in PTSD. Mitochondria play a central role in several physiologic processes underlying PTSD symptomatology, including abnormal fear learning, brain network activation, synaptic plasticity, steroidogenesis, and inflammation. Here we outline several potential mechanisms by which inherited (genetic) or acquired (environmental) mitochondrial dysfunction or suboptimal mitochondrial function, may contribute to PTSD symptomatology and increase susceptibility to PTSD. The proposed pathogenic role of mitochondria in the pathophysiology of PTSD has important implications for prevention and therapy, as antidepressants commonly prescribed for patients with PTSD have been shown to inhibit mitochondrial function, while alternative therapies shown to improve mitochondrial function may prove more efficacious.
Regional Distribution, Asymmetry, and Clinical Correlates of Tau Uptake on [ 18 F]AV-1451 PET in Atypical Alzheimer’s Disease
Tetzloff, Katerina A. , Graff‐Radford, Jonathan , Martin, Peter R. , Tosakulwong, Nirubol , Senjem, Matthew L. , Spychalla, Anthony J., Drubach, Daniel A., Jack, Clifford R. , Lowe, Val J. , Josephs, Keith A. , Whitwell, Jennifer L. , Jack, Clifford R , Senjem, Matthew L , Machulda, Mary M. , Duffy, Joseph R. , Clark, Heather M. , Schwarz, Christopher G.

Mayo Clinic

Journal of Alzheimer’s Disease | March 28, 2018 | Volume: 62 | Issue: 4 | Pages: 1713-1724

10.3233/jad-170740 | PMID 29614676 Get It

Background: Despite common pathology, Alzheimer’s disease (AD) can have multiple clinical presentations which pathological studies suggest result from differences in the regional distribution of tau pathology. Positron emission tomography (PET) ligands are now available that can detect tau proteins in vivo and hence can be used to investigate the biological mechanisms underlying atypical AD. Objective: To assess regional patterns of tau uptake on PET imaging in two atypical AD variants, posterior cortical atrophy (PCA) and logopenic progressive aphasia (lvPPA). Methods: Eighteen PCA and 19 lvPPA subjects that showed amyloid-β deposition on PET underwent tau-PET imaging with [ 18 F]AV-1451. Group comparisons of tau uptake in PCA and lvPPA were performed using voxel-level and regional-level analyses. We also assessed the degree of lobar tau asymmetry and correlated regional tau uptake to age and performance on clinical evaluations. Results: Both syndromes showed diffuse tau uptake throughout all cortical regions, although PCA showed greater uptake in occipital regions compared to lvPPA, and lvPPA showed greater uptake in left frontal and temporal regions compared to PCA. While lvPPA showed predominant left-asymmetric tau deposition, PCA was more bilateral. Younger subjects showed greater tau uptake bilaterally in frontal and parietal lobes than older subjects, and sentence repetition, Boston naming test, simultanagnosia, and visuoperceptual function showed specific regional tau correlates. Conclusion: Tau deposition is closely related to clinical presentation in atypical AD with age playing a role in determining the degree of cortical tau deposition.
In Reply
Lenz, Charles J., Wysokiński, Waldemar E. , McBane, Robert D.

Mayo Clinic

Obstetrics & Gynecology | March 27, 2018 | Volume: 131 | Issue: 4 | Pages: 741-742

10.1097/aog.0000000000002551 | PMID 29578970 Get It

Regarding the “Evaluation of patients with fibrotic interstitial lung disease: A Canadian Thoracic Society position statement”
Mura, Marco , McCormack, David G. , Fruchter, Oren , Kramer, Mordechai R., Colby, Thomas V. , Wells, Athol U. , Moran‐Mendoza, Onofre , Poletti, Venerino , Tomassetti, Sara

Mayo Clinic

Canadian Journal of Respiratory, Critical Care, and Sleep Medicine | March 27, 2018 | Volume: 2 | Issue: 3 | Pages: 182-183

10.1080/24745332.2018.1443296 Get It